The nature of pharmacopoeial specifications for bulk drug substances 25-30 years ago and the analytical methods used at that time are briefly reviewed. Since then the concept of characterizing drug substances by controlling impurities has been developed in pharmacopoeias. This concept is examined in
β¦ LIBER β¦
Required functionality of PACS from clinical point of view
β Scribed by F.H. Barneveld Binkhuysen
- Book ID
- 107769722
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 436 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0020-7101
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Purity requirements from a pharmacopoeia
β
C.A. Johnson
π
Article
π
1986
π
Elsevier Science
π
English
β 457 KB
Current views on the functionalities of
β
O. Ratib
π
Article
π
1992
π
Elsevier Science
π
English
β 532 KB
Clinical research from the point of view
β
Porro G. Salvini
π
Article
π
1997
π
Springer Milan
π
English
β 270 KB
Fat replacers β Requirements from a nutr
β
Grossklaus, Rolf
π
Article
π
1996
π
John Wiley and Sons
β 727 KB
There is a demand for development of low-fat products including fat replacers to limit the intake of total fat. The objective ofthis review is to show the requirements that are necessary for the assessment of the risks and benefits of a new fat replacer. An ideal fat replacer should be completely sa
REQUIREMENTS OF NEW ANTITUBERCULAR DRUGS
β
B. Fust
π
Article
π
2006
π
John Wiley and Sons
π
English
β 466 KB
Osteoporosis from the point of view of t
β
J. SzΕ©cs
π
Article
π
1994
π
SP BirkhΓ€user Verlag Basel
π
English
β 433 KB